Anika Therapeutics ANIK
NASDAQ ANIK
$19.10 -0.26 (-1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Anika Therapeutics (ANIK) Other Accumulated Expenses (2011 - 2026)

Updated

Anika Therapeutics (ANIK) reported Other Accumulated Expenses of $326,000 for Q2 2026, down 49.1% from $641,000 a year earlier and down 31.9% from the prior quarter.

Analysis

Anika Therapeutics (ANIK) Other Accumulated Expenses (2011 - 2026) Analysis & Trends

At the end of FY2025, Anika Therapeutics posted Other Accumulated Expenses of $468,000, down 38.8% from FY2024.

  • Other Accumulated Expenses has a five-year compound annual growth rate of -14.0% (FY2020 to FY2025).
  • By year, Other Accumulated Expenses came in at $765,000 in FY2024 (+126.3%), $338,000 in FY2023 (-33.7%), $510,000 in FY2022 (-51.8%) and $1.06 million in FY2021 (+6.3%).
  • The Q2 2026 figure ranks as the lowest quarterly Other Accumulated Expenses since Q2 2018.
  • Year over year, Other Accumulated Expenses has now declined in each of the last three quarters, with growth averaging 19.9% over the last eight quarters.
  • The high point for year-over-year Other Accumulated Expenses in five years was Q4 2024 (growth of 126.3%); the low point was Q3 2022 (a decline of 97.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $479,000 (Q1 2026), $468,000 (Q4 2025) and $750,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Anika Therapeutics 255.62 Mn -10.93 Mn 21.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 326,000.00
Mar 31, 2026 479,000.00
Dec 31, 2025 468,000.00
Sep 30, 2025 750,000.00
Jun 30, 2025 641,000.00
Mar 31, 2025 776,000.00
Dec 31, 2024 765,000.00
Sep 30, 2024 378,000.00
Jun 30, 2024 517,000.00
Mar 31, 2024 477,000.00
Dec 31, 2023 338,000.00
Sep 30, 2023 513,000.00
Jun 30, 2023 542,000.00
Mar 31, 2023 575,000.00
Dec 31, 2022 510,000.00
Sep 30, 2022 496,000.00
Jun 30, 2022 1.03 Mn
Mar 31, 2022 1.15 Mn
Dec 31, 2021 1.06 Mn
Sep 30, 2021 17.34 Mn
API Access

Anika Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ANIK&period=max&api_key=YOUR_API_KEY